FIELD: medicine. SUBSTANCE: method involves applying pathological brain zone perfusion with solutions of pharmacological preparations and neurospecific proteins. Geometric pattern and vascular volume changes are carried out by means of multichannel modeling operators, when the conditions of blood vessels-brain tissue correspondence are satisfied as being physiological. Lesion focus is concurrently irradiated with acoustic electromagnetic field. Remodeling effectiveness is evaluated by applying computer tomography and angiography methods and from some patient brain functions repair being observed according to clinical manifestations. Perfusion is carried out in continuous mode during 2-10 days with 0.025 ml cerebrolysin per 1 ml of physiological salt solution administered in combination with nootropic preparations and neurospecific protein solutions and vascular growth factors at perfusion rate of 15-30 ml/h. Daily perfusion volume is equal to 400-500 ml. Electromagnetic stimulation is carried out using extremely high frequency oscillator in millimetric bandwidth at 5.7 or 7.2 GHz 1-3 times a day during 10-15 min. EFFECT: enhanced effectiveness of therapeutic action. 3 cl
Title | Year | Author | Number |
---|---|---|---|
BIOENGINEERING METHOD FOR BRAIN FUNCTIONS REPAIR | 1998 |
|
RU2152038C1 |
METHOD OF PREPARING HUMAN EMBRYONAL NEURONS PREPARATION FOR CYTOTRANSFUSION | 1998 |
|
RU2146932C1 |
IMPLANTED NEUROENDOPROSTHETIC SYSTEM, METHOD OF OBTAINING IT AND METHOD OF CARRYING OUT RECONSTRUCTIVE NEUROSURGICAL OPERATION | 2008 |
|
RU2394593C2 |
METHOD OF TREATING ENCEPHALOPATHY | 2011 |
|
RU2464049C1 |
METHOD FOR CARRYING OUT COMBINED TREATMENT OF RECTAL CANCER CASES | 2004 |
|
RU2269341C1 |
METHOD FOR REMOTE ELECTROMAGNETIC MULTIWAVE RADIO NEUROENGINEERING OF HUMAN BRAIN | 2015 |
|
RU2621547C2 |
APPLICATION OF BETA-HYDROXYBUTYRATE OR ITS PHARMACEUTICALLY ACCEPTABLE SALTS FOR PREPARATION OF MEDICATION WHICH POSSESSES CYTOPROTECTIVE ACTIVITY, INCLUDING NEUROPROTECTIVE, CARDIOPROTECTIVE, ANTI-ISCHEMIC, ANTI-HYPOXIC, ANTI-STRESS, ACTOPROTECTIVE AND ADAPTOGENIC ACTIVITY, MEDICATION AND METHOD OF PREVENTION, RELIEF AND TREATMENT BY MEANS OF SAID MEDICATION | 2009 |
|
RU2426535C2 |
METHOD OF TREATING ACUTE ISCHEMIC AND HEMORRHAGIC CEREBROVASCULAR DISEASE | 2010 |
|
RU2477637C2 |
BIOMEDICAL CELL PRODUCT FOR THE TREATMENT OF ONCOLOGICAL, NEURODEGENERATIVE, AUTOIMMUNE DISEASES AND INJURIES OF THE BRAIN AND SPINAL CORD | 2021 |
|
RU2798554C2 |
LOCAL VASCULAR DELIVERY OF mTOR INHIBITORS IN COMBINATION WITH PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR STIMULATORS | 2008 |
|
RU2510654C2 |
Authors
Dates
2000-06-27—Published
1998-12-09—Filed